JOSEPH RICHARD: Open Payments
NPI 1700892346 · MCCOMB, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,518 in 111 payments from 15 companies in 2025. Trend: 2023 $1,477 · 2024 $1,229 · 2025 $2,518
Food & beverage: $2,434Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $578 |
| Janssen Biotech, Inc. | 19 | $435 |
| Madrigal Pharmaceuticals | 9 | $402 |
| GENZYME CORPORATION | 8 | $248 |
| Regeneron Healthcare Solutions, Inc. | 6 | $176 |
| Ardelyx, Inc. | 7 | $144 |
| QOL Medical, LLC | 5 | $125 |
| Phathom Pharmaceuticals, Inc. | 4 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Gilead Sciences, Inc. | 3 | $59 |
Products named: TREMFYA, DUPIXENT, REZDIFFRA, RINVOQ, IBSRELA, Sucraid, CREON, LINZESS.
Industry payments across MS — which companies pay providers there.
